Eisai is a human health care company that gives first thought to patients and their families, and to increasing the benefits that health care provides. Eisai concentrates its R&D activities in Neuroscience, Oncology and Vascular/Immunological reaction.
Eisai is committed to the development of innovative solutions in the therapeutic area of epilepsy and addressing the unmet medical needs of patients with epilepsy. Eisai is proud to currently market more epilepsy products in Europe than any other company.
Eisai is dedicated to discovering, developing and producing innovative oncology therapies that can improve and prolong the lives of cancer patients around the world.